Recent Company News

• 07:47 PM ET Dec 02, 2025
  

  StreetAccount Summary - Trading higher/lower: Australia & New Zealand midday

• 06:08 PM ET Jan 29, 2026
  

  Alterity Therapeutics reports Q2 net cash from / (used in) operating activities (A$5.3M) - Appendix 4C (A$0.01, 0.00)

• 07:49 PM ET Dec 15, 2025
  

  StreetAccount Summary - Australia unusual volume traders

• 04:10 PM ET Dec 16, 2025
  

  Alterity Therapeutics initiated speculative buy at Canaccord Genuity (A$0.01, 0.00)